Vimarsana
Biggest News Aggregation in the World

Page 3 - Medication Guide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medication Guide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medication Guide Today - Breaking & Trending Today

Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands - Vimarsana News

Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands

Published: April 23, 2024

Consumers Can Apply for a Chance to Be Featured in Upcoming Campaigns for BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, the Allergan Aesthetics Loyalty Rewards ProgramIRVINE,...

Source: marketscreener.com
Related Topics:
Jasson GilmoreAsmeret Berhe LumaxTomi TalabiLou GehrigAllergan Aesthetics Loyalty Rewards ProgramBeauty ClubProduct Support DepartmentConsumers Can ApplyUpcoming CampaignsAllergan Aesthetics Loyalty RewardsAllergan AestheticsSenior Vice PresidentCosmetic Executive WomenBlack Beauty RosterBlack Beauty ClubCosmetic ImportantMedication GuideProduct InformationBoxed WarningInjectable Gel Fillers ImportantUltra Plus
UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING - Vimarsana News

UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING

Published: April 12, 2024

/PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of Neurology (AAN)...

Source: prnewswire.com
Related Topics:
United StatesMaple GrovePrnewswire Upsher Smith LaboratoriesAmerican Academy Of Neurology Annual MeetingUpsher Smith LaboratoriesProgram At BoothAmerican Academy Of NeurologyBora GroupBora Pharmaceutical Co LtdSmith LaboratoriesAnnual MeetingOral SolutionAmerican AcademyNeurology Annual MeetingImportant Safety InformationBoxed WarningPermanent Vision LossComplex Partial SeizuresMedication GuidePrescribing InformationVigabatrin Risk EvaluationMitigation StrategyMedical PharmaceuticalsHealth Care Amp Hospitals
Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX® (testosterone undecanoate) CII Capsules - Vimarsana News

Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX® (testosterone undecanoate) CII Capsules

Published: April 11, 2024

/PRNewswire/ -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, today announced...

Source: prnewswire.com
Related Topics:
United StatesAmyb OdonnellJamess BernsteinAndreb AraujoThomasg TravisonShalin ShahJohnb MckinlayVarant KupelianJ Clin EndocrinolMarius PharmaceuticalsData PublishedTherapeutic AdvancesHelping Restore Testosterone LevelsFree TestosteroneOral TestosteroneMarius PharmaceuticalImportant Safety InformationBoxed WarningSafety InformationFull Prescribing InformationMedication GuidePopulation Level DeclineSerum Testosterone LevelsAmerican MenHealth Care Amp Hospitals
IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial - Vimarsana News

IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial

Published: April 5, 2024

First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial ...

Source: marketscreener.com
Related Topics:
United StatesUnited KingdomNoord HollandSuresh SenanSusan GalbraithDaiichi SankyoLungevity FoundationWorld Health OrganizationInternational Agency For Research On CancerAmerican Cancer SocietyNational Cancer InstituteAmsterdam University Medical CenterLung Ambition AllianceExecutive Vice PresidentFatal Immune Mediated AdverseMediated NephritisStevens Johnson SyndromeFull Prescribing InformationMedication GuideSouth AmericaRare DiseasesCell LungAccessed AprilRelapsed Small Cell Lung CancerSmall Cell Lung Cancer
World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults -April 04, 2024 at 01:54 am EDT - Vimarsana News

World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults -April 04, 2024 at 01:54 am EDT

Published: April 4, 2024

Antibody persistence of a single-doselive-attenuated chikungunya virus vaccine in adults. World Vaccine Congress, Washington 03-Apr-2024 ...

Source: marketscreener.com
Related Topics:
District Of ColumbiaUnited StatesSouth AfricaSouth AfricanSusanne Eder LingelbachInstituto ButantanIndianj DermatolVp Clinical DevelopmentA Major Public Health ThreatWorld Vaccine CongressCenters For DiseaseHealth CanadaDevelopment StatusVaccine CongressIntegrated ExpertiseLead PhaseJapanese EncephalitisCentral AmericaPrescribing InformationMedication GuideEnterotoxigenic EscherichiaMajor Public Health ThreatLatin AmericaTropical DiseasesAcute Morbidity